It is almost certainly going to ripping expensive, in my opinion. So much so, it will probably be out of reach for most balding folks.
A few reasons why it will be expensive:
- It’s a brand new drug, and new drugs nowadays are generally expensive.
- Because it’s a new drug, there are no generic alternatives.
- It’s a one-of-a-kind treatment, the only drug in its class (and therefore, no direct competition to help bring the cost down).
- It’s being hailed as a ‘game-changer’. A high-performing drug can demand a higher sticker price.
- It’s approved use will be to treat severe asthma that cannot be controlled with other medications. In other words, sales of the drug will not be driven by volume (lots of patients taking it), but by a small subset of asthma patients, whom will be charged a lot of money for the drug (Novartis has to make their money somehow).
- The cost of other asthma medications, some of which run into the hundreds of dollars per month (Zileuton, another unique oral drug for asthma that was released about 20 years ago, is an example).
How expensive will it be without insurance? Put it this way, a one month supply of oral Zileuton tablets for asthma, without insurance, costs about $3300 USD at my local Walmart. I think it’s probable that a month supply of fevi will also run into the thousands of dollars, even more expensive than Zileuton. Needless to say, this is both cost-prohibitive, and poor value (it’s effect on hair growth is nowhere near strong enough to justify spending that much money – you are better off getting multiple hair transplant treatments if you plan on coughing up that much dough).
Good comment !
I agree.
Btw, if Fevipiprant is easy to synthetise...maybe we could be able to get it a lot cheaper from a china lab.